scholarly article | Q13442814 |
P8978 | DBLP publication ID | journals/jcisd/ParkCA13 |
P356 | DOI | 10.1021/CI400225W |
P932 | PMC publication ID | 3787069 |
P698 | PubMed publication ID | 23927370 |
P2093 | author name string | Rommie E Amaro | |
Luke Czapla | |||
Jiho Park | |||
P2860 | cites work | Structural basis for androgen specificity and oestrogen synthesis in human aromatase | Q24314572 |
Anisotropic solvent model of the lipid bilayer. 2. Energetics of insertion of small molecules, peptides, and proteins in membranes | Q24596369 | ||
Membrane position of ibuprofen agrees with suggested access path entrance to cytochrome P450 2C9 active site | Q24609983 | ||
Computational identification of a transiently open L1/S3 pocket for reactivation of mutant p53 | Q24628577 | ||
SwissParam: A fast force field generation tool for small organic molecules | Q27136894 | ||
Motion and flexibility in human cytochrome p450 aromatase | Q27308070 | ||
Applying Molecular Dynamics Simulations to Identify Rarely Sampled Ligand-bound Conformational States of Undecaprenyl Pyrophosphate Synthase, an Antibacterial Target | Q27666848 | ||
Novel Aromatase Inhibitors by Structure-Guided Design | Q27672328 | ||
Antibacterial drug leads targeting isoprenoid biosynthesis | Q27675524 | ||
All-atom empirical potential for molecular modeling and dynamics studies of proteins | Q27860468 | ||
VMD: visual molecular dynamics | Q27860554 | ||
UCSF Chimera--a visualization system for exploratory research and analysis | Q27860666 | ||
Scalable molecular dynamics with NAMD | Q27860718 | ||
Epitope characterization of an aromatase monoclonal antibody suitable for the assessment of intratumoral aromatase activity | Q28472079 | ||
Novel naphthalene-based inhibitors of Trypanosoma brucei RNA editing ligase 1 | Q28475269 | ||
OPM database and PPM web server: resources for positioning of proteins in membranes | Q28740946 | ||
Extending the treatment of backbone energetics in protein force fields: limitations of gas-phase quantum mechanics in reproducing protein conformational distributions in molecular dynamics simulations | Q29547631 | ||
OPM: orientations of proteins in membranes database | Q29616317 | ||
Update of the CHARMM all-atom additive force field for lipids: validation on six lipid types | Q29616710 | ||
The ins and outs of cytochrome P450s. | Q30356342 | ||
The preference of tryptophan for membrane interfaces. | Q31997161 | ||
Hybrid dual aromatase-steroid sulfatase inhibitors with exquisite picomolar inhibitory activity | Q33598615 | ||
X-ray structure of human aromatase reveals an androgen-specific active site | Q33679045 | ||
Single-molecule height measurements on microsomal cytochrome P450 in nanometer-scale phospholipid bilayer disks | Q34067351 | ||
Positively charged amino acid residues can act as topogenic determinants in membrane proteins | Q34323545 | ||
Discovery of a novel binding trench in HIV integrase. | Q34546744 | ||
Non-bisphosphonate inhibitors of isoprenoid biosynthesis identified via computer-aided drug design. | Q35163073 | ||
Higher order organization of human placental aromatase | Q35552222 | ||
Molecular characterization of aromatase | Q35659379 | ||
MOLEonline 2.0: interactive web-based analysis of biomacromolecular channels | Q36088495 | ||
Multistructural hot spot characterization with FTProd | Q36581069 | ||
An improved relaxed complex scheme for receptor flexibility in computer-aided drug design | Q36838120 | ||
Organization of cytochrome P450 enzymes involved in sex steroid synthesis: PROTEIN-PROTEIN INTERACTIONS IN LIPID MEMBRANES. | Q37446094 | ||
Dual aromatase-steroid sulfatase inhibitors | Q40117552 | ||
Novel sulfonanilide analogues suppress aromatase expression and activity in breast cancer cells independent of COX-2 inhibition | Q40316159 | ||
ARIMIDEX: a new oral, once-a-day aromatase inhibitor. | Q40455026 | ||
Letrozole (CGS 20267), a new oral aromatase inhibitor for the treatment of advanced breast cancer in postmenopausal patients | Q41463849 | ||
Phase I and endocrine study of exemestane (FCE 24304), a new aromatase inhibitor, in postmenopausal women | Q42455423 | ||
Studies on the lipid composition of the rat liver endoplasmic reticulum after induction with phenobarbitone and 20-methylcholanthrene | Q42581865 | ||
Dynamics, hydration, and motional averaging of a loop-gated artificial protein cavity: the W191G mutant of cytochrome c peroxidase in water as revealed by molecular dynamics simulations | Q42629821 | ||
First dual aromatase-steroid sulfatase inhibitors | Q43944866 | ||
Fast three dimensional pharmacophore virtual screening of new potent non-steroid aromatase inhibitors. | Q46203919 | ||
Structure-activity relationships of new A,D-ring modified steroids as aromatase inhibitors: design, synthesis, and biological activity evaluation. | Q46725647 | ||
Reconstitution and imaging of a membrane protein in a nanometer-size phospholipid bilayer | Q47279890 | ||
Reversible peptide folding in solution by molecular dynamics simulation | Q47812843 | ||
Improved Treatment of Ligands and Coupling Effects in Empirical Calculation and Rationalization of pKa Values. | Q51550011 | ||
Dynamic structures of adrenocortical cytochrome P-450 in proteoliposomes and microsomes: protein rotation study | Q54255625 | ||
Lead optimization providing a series of flavone derivatives as potent nonsteroidal inhibitors of the cytochrome P450 aromatase enzyme | Q56997666 | ||
Letrozole (CGS 20267). A phase I study of a new potent oral aromatase inhibitor of breast cancer | Q72112429 | ||
CHARMM-GUI: a web-based graphical user interface for CHARMM | Q80900573 | ||
Influence of the membrane lipophilic environment on the structure and on the substrate access/egress routes of the human aromatase enzyme. A computational study | Q84201175 | ||
P433 | issue | 8 | |
P921 | main subject | ligand binding | Q61659151 |
P304 | page(s) | 2047-2056 | |
P577 | publication date | 2013-08-09 | |
P1433 | published in | Journal of Chemical Information and Modeling | Q3007982 |
P1476 | title | Molecular simulations of aromatase reveal new insights into the mechanism of ligand binding | |
P478 | volume | 53 |
Q37667038 | Acquired CYP19A1 amplification is an early specific mechanism of aromatase inhibitor resistance in ERα metastatic breast cancer |
Q35853865 | Alterations in ubiquitin ligase Siah-2 and its corepressor N-CoR after P-MAPA immunotherapy and anti-androgen therapy: new therapeutic opportunities for non-muscle invasive bladder cancer. |
Q21146741 | Anatomy of enzyme channels |
Q38397344 | Computational solvent mapping in structure-based drug design |
Q93126733 | Differing Membrane Interactions of Two Highly Similar Drug-Metabolizing Cytochrome P450 Isoforms: CYP 2C9 and CYP 2C19 |
Q38691180 | Molecular dynamics investigations of membrane-bound CYP2C19 polymorphisms reveal distinct mechanisms for peripheral variants by long-range effects on the enzymatic activity. |
Q37025619 | Recent Progress in the Discovery of Next Generation Inhibitors of Aromatase from the Structure-Function Perspective |
Q94461738 | The Effect of Force-Field Parameters on Cytochrome P450-Membrane Interactions: Structure and Dynamics |
Q47779502 | Working at the membrane interface: Ligand-induced changes in dynamic conformation and oligomeric structure in human aromatase |
Search more.